Liam Ratcliffe Sells 13,358 Shares of Arvinas, Inc. (NASDAQ:ARVN) Stock

10:16am, Wednesday, 17'th Nov 2021 Transcript Daily
Arvinas, Inc. (NASDAQ:ARVN) Director Liam Ratcliffe sold 13,358 shares of the firms stock in a transaction that occurred on Wednesday, November 10th. The stock was sold at an average price of $88.20, for a total value of $1,178,175.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at []
Related Stocks: DRNA , RGNX , ARWR , AMYT , ARVN , NGM , HARP , GLPG ,

Arvinas, Inc. (NASDAQ:ARVN) Shares Acquired by Amalgamated Bank

01:12pm, Tuesday, 16'th Nov 2021 Transcript Daily
Amalgamated Bank increased its holdings in shares of Arvinas, Inc. (NASDAQ:ARVN) by 60.1% during the 2nd quarter, Holdings Channel.com reports. The fund owned 8,241 shares of the companys stock after buying an additional 3,092 shares during the period. Amalgamated Banks holdings in Arvinas were worth $635,000 as of its most recent filing with the Securities []

Arvinas, Inc. (NASDAQ:ARVN) Director Sells $1,806,373.08 in Stock

04:16am, Tuesday, 16'th Nov 2021 Transcript Daily
Arvinas, Inc. (NASDAQ:ARVN) Director Liam Ratcliffe sold 21,284 shares of the businesss stock in a transaction dated Monday, November 15th. The stock was sold at an average price of $84.87, for a total transaction of $1,806,373.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this []
NEW HAVEN, Conn., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today anno
Arvinas, Inc. (ARVN) delivered earnings and revenue surprises of -132.98% and -96.40%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Kymera: Targeting The Protein Degradation Space
The stock price of Arvinas (NASDAQ: ARVN), a biopharmaceuticals company focused on oncology treatments based on targeted protein degradation, reached an all-time high of $108 in July of this year befo
The Dow lost 0.4%, the S&P 500 fell 0.8%, and the Nasdaq dropped 1.5%. Find opportunities in today's market with the best short plays from Q.ai's artificial intelligence.
The Dow Jones fell 167 points, the S&P 500 dipped 0.5%, and the Nasdaq dropped 0.7%. Find opportunities in today's market with the top short plays from Q.ai's deep learning algorithms.
The indices ticked up with the Dow Jones rising 142 points or 0.4%, the S&P 500 gaining 0.4%, and the Nasdaq bouncing 0.5%. Find opportunities in today's market with the best short plays from Q.ai's d
The Dow Jones and S&P 500 rose about 0.3%, while the Nasdaq climbed 0.4%. Make the most of this market with today's best short plays from Q.ai's deep learning algorithms.
Analysts are extremely concerned about the Delta variant of Covid-19, with hospitalizations increasing across the country and cases hitting new peaks in recent weeks. Find opportunities in today's mar
The Dow Jones fell about 68 points or 0.2%, and the S&P 500 and the Nasdaq dipped about 0.1% each. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.
The Dow Jones ticked down 14 points, the S&P 500 was flat, and the Nasdaq rose about 0.2%. Find opportunities in today's market with the best short plays from Q.ai's artificial inteligence.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE